Optimizing the association between disability and biological markers in MS
Nynke F. Kalkers(OLVG), Frederik Barkhof(Netherlands Institute for Neuroscience), Jonas A. Castelijns(Alkermes (Ireland)), Marianne A.A. van Walderveen(Alkermes (Ireland)), H.J. Adèr(University of Amsterdam), Elisabeth Bergers(Alkermes (Ireland)), Chris H. Polman(Vrije Universiteit Amsterdam), Joost Bot(Hermes Arzneimittel (Germany))
Cited by 135
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k